Yoshihiko Shibayama

Low expression levels of micro<scp>RNA</scp>‐124‐5p correlated with poor prognosis in colorectal cancer via targeting of <scp>SMC</scp>4

Takafumi Jinushi, Yoshihiko Shibayama, Ichiro Kinoshita et al. · Cancer Medicine · 2014 · 85 citations · Full text

Medicine, Molecular Biology, Oncology +17

Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib

Yoshihiko Shibayama, Kou Nakano, Hiroshi Maeda et al. · Biological and Pharmaceutical Bulletin · 2011 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients

Yoshihiko Shibayama, Takeshi Kondo, Hiroki Ohya et al. · Oncology Reports · 2015 · 55 citations · Full text

Medicine, Cancer Biology, Oncology +14

Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats

Yoshihiko Shibayama, Kazami Ushinohama, Ryuji Ikeda et al. · Cancer Science · 2006 · 45 citations · Full text

Medicine, Biochemistry, Pharmacology +15

Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells

Ryuji Ikeda, Xiaofang Che, Tatsuya Yamaguchi et al. · Cancer Science · 2005 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13